Henan Lingrui Pharmaceutical Co Ltd
SSE:600285

Watchlist Manager
Henan Lingrui Pharmaceutical Co Ltd Logo
Henan Lingrui Pharmaceutical Co Ltd
SSE:600285
Watchlist
Price: 20.81 CNY -3.88% Market Closed
Market Cap: 11.6B CNY
Have any thoughts about
Henan Lingrui Pharmaceutical Co Ltd?
Write Note

Henan Lingrui Pharmaceutical Co Ltd
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Henan Lingrui Pharmaceutical Co Ltd
Gross Profit Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
Henan Lingrui Pharmaceutical Co Ltd
SSE:600285
Gross Profit
ÂĄ2.6B
CAGR 3-Years
10%
CAGR 5-Years
10%
CAGR 10-Years
19%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Gross Profit
ÂĄ9.1B
CAGR 3-Years
5%
CAGR 5-Years
5%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Gross Profit
ÂĄ4.8B
CAGR 3-Years
13%
CAGR 5-Years
17%
CAGR 10-Years
21%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Gross Profit
ÂĄ22.1B
CAGR 3-Years
-4%
CAGR 5-Years
3%
CAGR 10-Years
14%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Gross Profit
ÂĄ10.5B
CAGR 3-Years
2%
CAGR 5-Years
5%
CAGR 10-Years
8%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Gross Profit
ÂĄ319.6m
CAGR 3-Years
-27%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Henan Lingrui Pharmaceutical Co Ltd
Glance View

Market Cap
11.7B CNY
Industry
Pharmaceuticals

Henan Lingrui Pharmaceutical Co., Ltd. engages in the production and sale of medicine and health products. The company is headquartered in Xinyang, Henan and currently employs 2,500 full-time employees. The company went IPO on 2000-10-18. The firm's products include emplastrum, tablets, capsules, ointments and others, applied in the treatment of diabetes mellitus, osteoarthritis, gastropathy, cardiovascular and cerebrovascular diseases, respiratory disease, gynecopathy and dermatopathy, among others. The firm distributes its products throughout China, with Henan Province and Beijing as its major markets.

Intrinsic Value
32.2 CNY
Undervaluation 35%
Intrinsic Value
Price

See Also

What is Henan Lingrui Pharmaceutical Co Ltd's Gross Profit?
Gross Profit
2.6B CNY

Based on the financial report for Sep 30, 2024, Henan Lingrui Pharmaceutical Co Ltd's Gross Profit amounts to 2.6B CNY.

What is Henan Lingrui Pharmaceutical Co Ltd's Gross Profit growth rate?
Gross Profit CAGR 10Y
19%

Over the last year, the Gross Profit growth was 11%. The average annual Gross Profit growth rates for Henan Lingrui Pharmaceutical Co Ltd have been 10% over the past three years , 10% over the past five years , and 19% over the past ten years .

Back to Top